Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT04922450 · UNKNOWN
Trial details
- NCT number
- NCT04922450
- Sponsor
- Hunan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-20
- Primary completion
- 2023-01-20
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.